Join

Compare · BDX vs BEAT

BDX vs BEAT

Side-by-side comparison of Becton Dickinson and Company (BDX) and Heartbeam Inc. (BEAT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BDX and BEAT operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • BDX is the larger of the two at $40.12B, about 811.7x BEAT ($49.4M).
  • Over the past year, BDX is down 14.9% and BEAT is down 46.5% - BDX leads by 31.7 points.
  • BDX has been more active in the news (12 items in the past 4 weeks vs 4 for BEAT).
  • BDX has more recent analyst coverage (25 ratings vs 8 for BEAT).
PerformanceBDX-14.85%BEAT-46.53%
2025-06-04+0.00%2026-06-03
MetricBDXBEAT
Company
Becton Dickinson and Company
Heartbeam Inc.
Price
$145.54+0.77%
$0.90+4.42%
Market cap
$40.12B
$49.4M
1M return
-0.50%
+5.16%
1Y return
-14.85%
-46.53%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NYSE
NASDAQ
IPO
2021
News (4w)
12
4
Recent ratings
25
8
BDX

Becton Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

BEAT

Heartbeam Inc.

HeartBeam, Inc., a medical technology company, primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease. It focuses on providing diagnostic data to help physicians with care management of patients with cardiovascular disease. The company is developing its telehealth product that comprises a credit card sized electrocardiograms machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is based in Santa Clara, California.

Latest BDX

Latest BEAT